Autism data hits ‘registration benchmark’ as Neurotech prepares for Phase III clinical trial by Adam Sheldon March 25, 2026March 26, 2026 Neurotech International has said data from its Phase II/III autism trial already sits within the range […]
News in brief: Vitura signs MedReleaf deal; Neurotech initiates first site for Phase 3 autism trial by Adam Sheldon March 17, 2026June 8, 2026
News in brief: Epsilon launches biotech arm; LGP sells WA facility for $7.8m; Neurotech partners with University of Sydney on Rett program by Adam Sheldon February 18, 2026June 8, 2026
Financial news in brief: Avecho; InhaleRx; Neurotech; Peak; Zelira; Argent by Adam Sheldon February 2, 2026June 8, 2026
Neurotech progresses ASD trial, inks deal with contract research organisation by Martin Lane April 10, 2024July 16, 2024
Neurotech International announces breakthrough results from autism study by Martin Lane July 8, 2022April 29, 2024
